Content :

Local environmental impact

Key issues

Many issues affect the local environmental footprint of a pharmaceutical group such as Sanofi:

• Various types of water usage
• Consumption of resources (raw materials and ingredients used to produce active ingredients and in the formulation of medicines and vaccines)
• Use of solvents for drug and vaccine synthesis and production phases
• Use of different materials to protect and package products
• Different types of emissions generated by the sites: These emissions include air emissions, wastewater effluents and waste of all kinds, and concern all types of sites – R&D sites, production sites for active ingredients, medicine and vaccine manufacturing sites, as well as logistics and administrative sites.

Sanofi’s commitment

Protecting the environment is a long-standing commitment at Sanofi. With numerous sites operating throughout the world, the Group strives to reduce the potential impact on the environment of manufacturing medicines and vaccines in order to reduce the local environmental footprint of its activities.

The HSE Department is responsible for overseeing initiatives to minimize environmental impact. All the Group’s sites receive information about these issues, and various initiatives are carried out to limit water consumption and wastewater discharge, preserve air quality, manage waste responsibly and remediate contaminated soil.